Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Validation of prognostic models of lung cancer Thomas Callender University College London PLCO Jun 21, 2021 PLCO-801
Prospective study of DNA repair functional assays and risk of lung cancer Zvi Livneh Weizmann Institute of Science PLCO Jun 14, 2021 2021-0018
Characterizing clonal expansion of large mosaic chromosomal alterations in leukocytes Mitchell Machiela National Cancer Institute PLCO Jun 14, 2021 2021-0014
Using circulating metabolomes to understand pancreatic cancer genotype and phenotype and to explore their potential for risk assessment and early detection Herbert Yu University of Hawaii Cancer Center PLCO Jun 14, 2021 2021-0013
The impact of pregnancy history on genome-wide methylation patterns in women with and without multiple sclerosis Vilija Jokubaitis Monash University PLCO May 21, 2021 PLCO-789
PLCO: Effects of high-dimensional genetic variation (GWAS) on PSA trajectories and their relationship with prostate cancer incidence Grace Hong NCI PLCO May 18, 2021 PLCO-787
Opioid Cohort Consortium (OPICO) to investigate the effects of opioid use on cancer incidence and mortality Mahdi Sheikh Internatioanl Agency for Research on Cancer (IARC - WHO) PLCO May 11, 2021 PLCO-784
AI system to infer a patient’s prostate cancer stage from clinical information trained on synthetic electronic health records Ali Kamen Siemens Healthineers PLCO May 11, 2021 PLCO-786
Decisions to perform invasive diagnostic procedures follow a probability curve based upon the risk of cancer: insights from lung, ovarian and prostate cancer from the PLCO dataset Fabien Maldonado Vanderbilt University Medical Center PLCO May 7, 2021 PLCO-778
Associations of inflammatory and insulinemic dietary patterns and risk of colorectal adenomas in men and women: Findings from the PLCO cohort Fred Tabung The Ohio State University PLCO May 7, 2021 PLCO-780
Joint modeling of longitudinal data and survival data in hidden markov model setting hong li medical university of south carolina PLCO May 7, 2021 PLCO-782
Deep Learning for Investigation of Relationship between Whole Slide Image Features, Biomarkers, and Clinical Outcomes in Cancer Patients Min Yuan Anhui Medical University PLCO May 7, 2021 PLCOI-783
Statistical methods issues for biomarker studies in cancer screening trials Ping Hu NCI PLCO Apr 30, 2021 PLCO-779
Efficient machine learning algorithms for investigating and comparing the risk factors of breast and prostate cancers among males and females Samaneh Rikhtehgaran Florida Atlantic University PLCO Apr 21, 2021 PLCO-777
Survival Analysis for Whole Slide Images based on Multiple Instance Learning Wei Wu Xiamen University PLCO Apr 20, 2021 PLCOI-776
Dynamic Risk Prediction of Prostate Cancer Development Using Longitudinal Biomarkers of PSA Ming Wang The Pennsylvania State University PLCO Apr 20, 2021 PLCO-775
Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer Jianjun Zhang Indiana University PLCO Apr 20, 2021 2020-0002
Impact of Exercise on Cancer Pathogenesis Lee Jones Memorial Sloan Kettering Cancer Center PLCO Apr 19, 2021 PLCO-769
Multi-modal learning in Chest X-rays Benjamin Hou Imperial College London PLCO Apr 19, 2021 PLCOI-774
CXR deep learning classifier Anton Konushin Third Opinion Platform LLC PLCO Apr 16, 2021 PLCOI-767